Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Camilla Huse, Ph.D.

Concepts (64)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Camilla Huse's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Camilla Huse has written about over time.
Aorta, Thoracic, 1 publications between 2021 and 2021, average publication date July 2021. Chemokine CCL2, 1 publications between 2021 and 2021, average publication date July 2021. Deoxyribonuclease (Pyrimidine Dimer), 1 publications between 2021 and 2021, average publication date July 2021. RNA, 2 publications between 2021 and 2022, average publication date December 2021. Leukocytes, 1 publications between 2022 and 2022, average publication date April 2022. Lymphocyte Count, 1 publications between 2022 and 2022, average publication date April 2022. Neutrophils, 1 publications between 2022 and 2022, average publication date April 2022. T-Lymphocyte Subsets, 1 publications between 2022 and 2022, average publication date April 2022. Viral Vaccines, 1 publications between 2022 and 2022, average publication date September 2022. Interleukin-6, 2 publications between 2022 and 2023, average publication date December 2022. Atherosclerosis, 2 publications between 2021 and 2024, average publication date January 2023. Extracellular Matrix, 2 publications between 2023 and 2024, average publication date February 2024. Leukocytes, Mononuclear, 1 publications between 2024 and 2024, average publication date June 2024. Chemokines, CXC, 1 publications between 2024 and 2024, average publication date October 2024.

To see the data from this visualization as text, click here.
Huse's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.